Abstract:Aim: To detect the expression of fragile histidine triad (FHIT) in normal colorectal tissue, colorectal adenoma and colorectal cancer (CRC) tissue, and to analyze its relationship with the clinicopathological features of CRC, and apoptosis-associated proteins (Bcl-2, Bax, survivin) and apoptosis in colorectal cancer.METHODS: FHIT mRNA analysis was performed by nested reverse transcription-polymerase chain reaction (RT-PCR) assay. Tissue microarray (TMA) was established to detect the expression of FHIT, Bcl-2, Bax and survivin genes in 80 CRC tissue specimens, 16 colorectal adenoma tissue specimens and 16 hemorrhoid (PPH) tissue specimens during the same period of time as the control. Citrate-microwave-SP was used as immunohistochemical method. The relationship between clinicopathological factors, such as differentiation grades and 5-year survival rate was observed. TUNEL assay was used to detect the apoptosis index in 80 CRC tissue specimens.RESULTS: Ten out of 26 (38.5%) CRC tissue specimens expressed aberrant FHIT transcripts, none of the aberrant FHIT transcripts was observed in the matched normal tissue and colorectal adenoma tissue by nested RT-PCR assay. The positive rate of FHIT gene expression in normal colorectal tissue, colorectal adenoma and carcinoma tissue was 93.75%, 68.75% and 46.25%, respectively. Clinicopathological analysis of patients showed that the decreased FHIT gene expression was not associated with age, sex, serum CEA levels, tumor site and size, histological classification. However, the expression of FHIT was correlated with differentiation grades, pathological stages, lymph node metastases and 5-year survival rate after operation. The positive rate of apoptosis-associated proteins (Bax, Bcl-2 and survivin) in CRC tissue was 72.50%, 51.25% and 77.50%, respectively. The expression of these apoptosis-associated proteins in CRC tissue was correlated with the expression of FHIT. The mean apoptosis index in FHIT negative tumors was significantly lower than that in FHIT positive tumors (5.41 +/- 0.23 vs 0.56 +/- 0.10, P < 0.01).CONCLUSION: The FHIT gene plays an important role in the regulation of apoptosis and decreased FHIT expression plays a key role in the initiation and progression of colorectal carcinoma. (c) 2007 The WJG Press. All rights reserved.

Down-Regulation of Fhit Inhibits Apoptosis of Colorectal Cancer: Mechanism and Clinical Implication

Decreased Fragile Histidine Triad Expression in Colorectal Cancer and Its Association with Apoptosis Inhibition

Regulation of Dna Methylation on the Expression of the Fhit Gene Contributes to Cervical Carcinoma Cell Tumorigenesis

Article Through Inhibiting STAT3 Phosphorylation and Nuclear Translocation

FHIT Promotes the Apoptosis of QBC939 by Reducing the Expression of Cyclin D1.

Aberrant FHIT expression is linked to bladder carcinogenesis and apoptosis.

Deletion of the FHIT Gene in Human Colorectal Cancer is Independent of High-Risk HPV Infection.

Expression of Fragile Histidine Triad in Primary Hepatocellular Carcinoma and Its Relation with Cell Proliferation and Apoptosis

Two-Hit Inactivation Of Fhit By Loss Of Heterozygosity And Hypermethylation In Breast Cancer

FHIT gene alterations in esophageal cancer and ulcerative colitis (UC)

[Reduction of FHIT Gene Expression in Primary Lung Cancer: Relationship with the Proliferation and Apoptosis of Tumor Cell].

[Effects of Ectogenous FHIT Gene on Reversing Malignant Phenotype of Human Lung Adenocarcinoma Cells A549].

Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.

FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway

[Allelic Loss and Down-Regulation of FHIT Gene Expression in Esophageal Squamous Cell Carcinoma].

Upregulation of FHIT Gene Expression in Endometrial Carcinoma by RNA Activation.

[Mutation and Abnormal Expression of FHIT Gene in Hypopharyngeal Carcinoma].

Clinicopathological Significance of Fragile Histidine Triad Transcription Protein Expression in Breast Carcinoma.

FHL1 Inhibits the Progression of Colorectal Cancer by Regulating the Wnt/β-Catenin Signaling Pathway

Effect of Fragile Histidine Triad Gene on Apoptosis of MGC-803 Gastric Cancer Cells

The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.